Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies.
The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment.
In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed)..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 62.6K |
| Three Month Average Volume | 2.6M |
| High Low | |
| Fifty-Two Week High | 15.00312 CAD |
| Fifty-Two Week Low | 8.47877 CAD |
| Fifty-Two Week High Date | 08 Mar 2024 |
| Fifty-Two Week Low Date | 01 Nov 2023 |
| Price and Volume | |
| Current Price | 10.92181 CAD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 4.26% |
| Thirteen Week Relative Price Change | -4.17% |
| Twenty-Six Week Relative Price Change | -19.35% |
| Fifty-Two Week Relative Price Change | -23.32% |
| Year-to-Date Relative Price Change | -18.24% |
| Price Change | |
| One Day Price Change | 2.29% |
| Thirteen Week Price Change | 2.56% |
| Twenty-Six Week Price Change | -11.32% |
| Five Day Price Change | 2.84% |
| Fifty-Two Week Price Change | -3.92% |
| Year-to-Date Price Change | -3.18% |
| Month-to-Date Price Change | 5.41% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 4.25065 CAD |
| Book Value Per Share (Most Recent Quarter) | 4.41835 CAD |
| Tangible Book Value Per Share (Last Fiscal Year) | 3.11864 CAD |
| Tangible Book Value Per Share (Most Recent Quarter) | 3.16354 CAD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 1.42307 CAD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 6.51323 CAD |
| Revenue Per Share (Trailing Twelve Months) | 7.30364 CAD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -143707.98563 CAD |
| Dividend Per Share (Trailing Twelve Months) | 0 CAD |
| Dividend Per Share (5 Year) | -143707.98563 CAD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 0.36454 CAD |
| Excluding Extraordinary Items (Trailing Twelve Months) | 0.33643 CAD |
| Normalized (Last Fiscal Year) | 0.38088 CAD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 0.38379 CAD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 0.35277 CAD |
| Including Extraordinary Items (Last Fiscal Year) | 0.36454 CAD |
| Including Extraordinary Items (Trailing Twelve Months) | 0.33643 CAD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.47917 CAD |
| Cash Per Share (Most Recent Quarter) | 0.32597 CAD |
| Cash Flow Per Share (Last Fiscal Year) | 1.14364 CAD |
| Cash Flow Per Share (Trailing Twelve Months) | 1.208 CAD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 0.2903 CAD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 8 |
| Cash Flow Revenue (Trailing Twelve Months) | 4 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 6.65% |
| Pretax Margin (Last Fiscal Year) | 7.86% |
| Pretax Margin (5 Year) | 10.92% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 61.63% |
| Gross Margin (Trailing Twelve Months) | 60.95% |
| Gross Margin (5 Year) | 62.57% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 7.83% |
| Operating Margin (Trailing Twelve Months) | 7.45% |
| Operating Margin (5 Year) | 10.77% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 5.60% |
| Net Profit Margin (Trailing Twelve Months) | 4.61% |
| Net Profit Margin (5 Year) | 10.09% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 27.77% |
| Tangible Book Value (5 Year) | 20.74% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 3.30% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 26.91% |
| Revenue Growth (3 Year) | 23.21% |
| Revenue Change (Trailing Twelve Months) | 31.75% |
| Revenue Per Share Growth | 22.77% |
| Revenue Growth (5 Year) | 11.70% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 33.67% |
| Total Debt (5 Year) | 16.85% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -36.80% |
| EPS Change (Trailing Twelve Months) | 27.73% |
| EPS Growth (3 Year) | 1.15% |
| EPS Growth (5 Year) | -31.17% |
| EBITDA | |
| EBITDA (5 Year) | 21.55% |
| EBITDA (5 Year Interim) | 23.39% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -17.62% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 4 |
| Price to Tangible Book (Most Recent Quarter) | 3 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 15 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 36 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 2.9M |
| Net Debt (Last Fiscal Year) | -5,377,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 2 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 32 |
| PE Normalized (Last Fiscal Year) | 29 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 27 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 64 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 10 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 32 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 3 |
| Price to Book (Most Recent Quarter) | 2 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 5 |
| Long Term Debt to Equity (Most Recent Quarter) | 9 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 0.00% |
| Payout Ratio (Trailing Twelve Months) | 0.00% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 48 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 80 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 19.1M |
| Free Cash Flow (Trailing Twelve Months) | 8.2M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | 10 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 7 |
| Total Debt to Equity (Most Recent Quarter) | 10 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 7.53% |
| Return on Assets (Trailing Twelve Months) | 6.05% |
| Return on Assets (5 Year) | 12.28% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 9.71% |
| Return on Equity (Trailing Twelve Months) | 8.46% |
| Return on Equity (5 Year) | 16.81% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 9.27% |
| Return on Investment (Trailing Twelve Months) | 7.64% |
| Return on Investment (5 Year) | 15.52% |